Clinical Trials Browser

Phase 1/2 × Completed × Tretinoin × Clear all

NCT04303169 2025-10-27

KEYMAKER-U02

Phase 1/2 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT04305041 2025-08-29

KEYMAKER-U02

Phase 1/2 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT03200847 2024-10-01

Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Phase 1/2 Completed

26 enrolled 13 charts

Melanoma

NCT02842827 2023-07-11

IMG-7289-CTP-101

Phase 1/2 Completed

45 enrolled 41 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02751255 2023-04-28

DARA/ATRA

Phase 1/2 Completed

Multiple Myeloma

NCT00175812 2015-06-24

Differentiation Induction in Acute Myelogenous Leukemia

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00995332 2015-06-24

Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute